Neurostimulation devices are generally used to diagnose and treat disorders of autonomic nervous system (ANS), central nervous system (CNS), and peripheral nervous system (PNS). Demand for neurostimulators is rising, as these devices help in nociceptive pain management and neuropathic pain management. They also help in the management of epilepsy, depression, and Parkinson’s disease. Demand for neurostimulation devices declined during the COVID-19 pandemic, which has hampered market revenue. The market in Asia Pacific is likely to expand at the fastest growth rate during the forecast period, primarily due to the increase in incidence of neurological disorders such as arthritis and osteoporosis in countries such as Japan and China.
Request a Sample @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=62178
Rise in Prevalence of Parkinson’s Disease to Drive Global Market
Parkinson’s disease is an age-related neurodegenerative disorder that affects large number of people across the world. It is characterized by muscle contraction, which leads to weakening of physical movement, tremors, muscle rigidity, and gait. It can affect multiple systems of the body.
According to the Parkinson’s Foundation, more than 10 million people live with Parkinson’s disease across the globe. Around one million people in the U.S. suffer from Parkinson’s disease. Nearly 60,000 people in the U.S. are estimated to be diagnosed with Parkinson’s disease each year. The exact number of patients is not known primarily due to the incompleteness and inconsistencies of prevalence studies and underdiagnosed cases.
According to the Global Burden of Disease Study, about 13 million people across the globe are likely to be affected by Parkinson’s disease by 2040. China accounts for the largest number of patients with Parkinson’s disease in the world. Currently, around 2.5 million people in the country are afflicted with Parkinson’s disease. This number is expected to double by the end of 2030. Currently, 1.7% of population of China above the age of 65 is affected by Parkinson’s disease.
According to VIARTIS, Albania has the highest prevalence rate of Parkinson’s disease of 800 per 100,000 persons in the world. The highest incidence rate of Parkinson’s disease is observed in France, with around 36 to 49 cases per 100,000. According to the European Parkinson’s Disease Association, currently, around 1.2 million people in the European Union are afflicted with Parkinson’s disease. About 260,000 people in Germany, 150,000 in Italy, and 120,000 people in the U.K. suffer from Parkinson’s disease.
Enquiry Before Buying: https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=62178
Technological Advancements and New Product Development to Boost Market
Increase in demand for improved product outcomes & efficiency have led to development of innovative products and technologies to address the unmet needs of patients as well as surgeons. In order to provide improved and alternative solutions to unmet medical needs in neurological disorders, companies have developed novel technologies and devices, such as neurostimulation equipment, to improve the overall quality of life of the affected patient population. In January 2019, Boston Scientific Corporation launched the Vercise Primary Cell and Vercise Gevia Deep Brain Stimulation system for the treatment of symptoms of Parkinson’s disease. In December 2018, Axonics Modulation Technological, Inc. filed the Premarket Approval Application (PMA) with the U.S. FDA for the rechargeable implantable sacral neurostimulation system. In January 2017, Abbott Laboratories launched the new Proclaim DRG neurostimulation system in Europe. The Proclaim DRG neurostimulation system is designed to deliver dorsal root ganglion (DRG) stimulation for patients suffering from chronic neuropathic pain. Abbott is the first and only company that offers DRG therapy and targeted relief for certain types of chronic pain. Thus, the key trend of development and commercialization of novel electrical stimulation devices is driving the global neurostimulation devices market.
Ask for a custom report: https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=62178
Launch of New Products with Updated Technologies to Propel Spinal Cord Stimulators Segment
The spinal cord stimulators segment accounted for dominant share of the global market in 2021. The segment is projected to grow at a high CAGR from 2022 to 2031.
High prevalence of chronic pain caused due to various reasons such as failed back surgery syndrome, cancer, traumatic pain, and nerve injuries; launch of new products with updated technologies in spinal cord stimulation; and favorable medical reimbursement policies in developed countries are projected to drive the segment during the forecast period.
About Transparency Market Research
Transparency Market Research registered at Wilmington, Delaware, United States, is a global market research firm that offers market analysis reports and business consulting. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyze information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
For More Research Insights on Leading Industries, Visit our YouTube channel –
https://www.youtube.com/channel/UC8e-z-g23-TdDMuODiL8BKQ
Contact Us:
Nikhil Sawlani
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: 1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
Blog: https://tmrblog.com
Email: [email protected]